VISTAGEN THERAPEUTICS, INC. Other Notes Payable, Current
VISTAGEN THERAPEUTICS, INC. (VTGN) had Other Notes Payable, Current of $4.16 million as of 2015-03-31, per its 10-Q filed 2016-02-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:OtherNotesPayableCurrent · last filed 2016-02-16
- 2015-03-31: Other Notes Payable, Current $4.16M.
| Period end | Other Notes Payable, Current |
|---|---|
| 2015-03-31 | $4.16M 10-Q · filed 2016-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |